Product Overview

Alternative Name: Miglustat, N-butyldeoxynojirimycin (NB-DNJ)

Development Status: Inactive

Target: Male

Mode: Non-hormonal

Delivery Type: Oral

Duration Type: Permanent

Description: Zavesca, a medication already approved for treating a rare genetic disorder, works as a male contraceptive for a particular strain of laboratory mouse. Exactly how Zavesca acts as a contraceptive for the mice is not known.

Updated date: May 30, 2018

Vertical Tabs


Project Phase: Discovery

Status Details:
  • Research on Zavesca as a male contraceptive has stopped as it was shown to not be effective in humans.

Download Product Report